Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares OutstandingShort-Term Debt repayments
Ratios

BioNexus Gene Lab (BGLC) Short-Term Debt repayments (2018 - 2025)

Historic Short-Term Debt repayments for BioNexus Gene Lab (BGLC) over the last 5 years, with Q3 2025 value amounting to $34187.0.

  • BioNexus Gene Lab's Short-Term Debt repayments rose 11735.54% to $34187.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$163166.0, marking a year-over-year increase of 1739.85%. This contributed to the annual value of -$1061.0 for FY2019, which is 17357.84% down from last year.
  • According to the latest figures from Q3 2025, BioNexus Gene Lab's Short-Term Debt repayments is $34187.0, which was up 11735.54% from -$196982.0 recorded in Q3 2024.
  • BioNexus Gene Lab's Short-Term Debt repayments' 5-year high stood at $34187.0 during Q3 2025, with a 5-year trough of -$196982.0 in Q3 2024.